CMR Statement โ ADIRONDACK Fragrance Oil
We hereby acknowledge that the following product contains the CMR mentioned hereafter:
CMR 1A according to regulation (EC) Nยฐ1272/2008, Annex VI as amended
/
CMR 1B according to regulation (EC) Nยฐ1272/2008, Annex VI as amended
/
CMR 2 according to regulation (EC) Nยฐ1272/2008, Annex VI as amended
/
CMR 2 according to regulation (EC) Nยฐ1272/2008, Annex VI as amended with positive opinion from SCCS
/
CMR 1A self-classified according to IOFI/IFRA Labeling manual and/or supplier data
/
CMR 1B self-classified according to IOFI/IFRA Labeling manual and/or supplier data
/
CMR 2 self-classified according to IOFI/IFRA Labeling manual and/or supplier data
| Components | CAS-No. | Concentration | Added | Natural Origin | Impurities |
|---|---|---|---|---|---|
| GAMMA TERPINENE | 99-85-4 | 0.005 % | / | 0.005 % | / |
The above data is provided to the best of our knowledge and/or according to our supplier's declarations to us as of the mentioned date.
Stock Fragrance โ Regulatory Affairs and Product Safety Department
This document cancels and replaces all preceding versions for this product.
Learn more: U.S. vs EU Fragrance Labeling ย ยทย How IFRA Limits Work
Frequently Asked Questions
What is a CMR statement for fragrance oil?
A CMR statement discloses whether a fragrance oil contains substances classified as Carcinogenic, Mutagenic, or Reprotoxic (CMR) under EU Regulation (EC) 1272/2008 (CLP). This documentation is required for professional supply and product safety assessments in the EU and UK.
Does Adirondack contain any CMR substances?
Please refer to the CMR Statement above for the complete assessment of Adirondack. Stock Fragrance follows EU CLP regulations for all CMR-related disclosures.
Why is CMR classification important for cosmetic formulators?
EU Cosmetics Regulation 1223/2009 prohibits CMR Category 1A and 1B substances in cosmetic products. Category 2 CMR substances may be permitted subject to SCCS scientific review. Formulators must verify CMR status for each ingredient when developing EU-compliant cosmetics.